Patent details

Basic Information

Publication number:

EP2000149

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP080138985

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Chimeric anti-CD20 antibody

French Title of Invention:

Anticorps chimérique anti-CD20

German Title of Invention:

Chimärischer Anti-CD20-Antikörper

SPC Number:

91620

Dates

Filing date:

12/11/1993

Grant date:

13/05/2009

EP Publication Date:

13/05/2009

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

10/12/2008

EP B1 Publication Date:

13/05/2009

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

12/11/2013

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

26/05/2009

 

 

Name:

Biogen Idec Inc.

Address:

14 Cambridge Center, Cambridge, MA 02142, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

10/06/2009

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

Leonard John E.

Address:

United States (US)

2

Name:

Reff Mitchell E.

Address:

United States (US)

3

Name:

Anderson Darrell R.

Address:

United States (US)

4

Name:

Newman Roland A.

Address:

United States (US)

5

Name:

Hanna Nabil

Address:

United States (US)

6

Name:

Rastetter William H.

Address:

United States (US)

Priority

1

Priority Number:

978891

Priority Date:

13/11/1992

Priority Country:

United States (US)

2

Priority Number:

149099

Priority Date:

03/11/1993

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 39/395;

Filing date	Document type	Number of pages